A newly renewed charter for the Advisory Committee on Immunization Practices (ACIP) could let Health Secretary Kennedy Jr. roll back or revisit vaccine-policy changes despite a federal court ruling that paused his overhaul.

The refreshed ACIP charter broadens who can serve and what the panel focuses on, potentially bringing back previously sidelined anti-vaccine voices and reshaping vaccine guidance.

The story centers on the clash between policy shifts and judicial limits, with implications for public perception and adherence to vaccine guidance.

Public health experts warn of longer-term consequences like increased vaccine hesitancy and slower FDA adoption of new vaccines if ACIP guidance remains unsettled.

A Massachusetts federal judge halted Kennedy’s remade ACIP, citing unqualified members and setting a 60-day window for the government to appeal.

Experts are divided: the charter could be seen as circumvention of the court block, or as an attempt to create an anti-vaccine tool that undermines confidence.

A DHHS spokesperson described the renewal as routine and not indicative of broader policy shifts, noting that next steps depend on official HHS announcements.

Analysts warn it remains unclear whether Kennedy will appoint a new ACIP, given careful vetting to withstand court scrutiny and political pressure ahead of elections.

The charter shifts to de-emphasize ACIP recommendations appearing in the CDC’s Morbidity and Mortality Weekly Report, altering how guidance is published and perceived.

Kennedy’s approach reportedly dismissed the existing ACIP, appointed vaccine-skeptical members, and broadened changes to the childhood schedule, reducing routine vaccines from 17 to 11 without clear justification.

While rhetoric around vaccines has cooled, Kennedy has redirected focus toward nutrition and microplastics, with reports of White House guidance to limit vaccine discussions before the midterms.

The broader project under Kennedy seeks to overhaul vaccine guidance and infrastructure, with a court ruling halting many changes as the White House appears to temper anti-vaccine rhetoric before elections.